P165: Dose‐related amelioration of peg‐interferon based retinal vasculitis

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2893|22|S2|101-101

ISSN： 1352-0504

Source： JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.22, Iss.S2, 2015-06, pp. : 101-101

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Retinal vasculitis

By  

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

PANCYTOPENIA AND VALPROIC ACID: A DOSE‐RELATED ASSOCIATION

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 48, Iss. 3, 2000-03 ,pp. : 349-350

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ribavirin dose reduction during telaprevir/ribavirin/peg‐interferon therapy overcomes the effect of the ITPA gene polymorphism

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 2, 2015-02 ,pp. : 166-174

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of CYP27B1+2838 promoter polymorphism in the treatment of chronic hepatitis B HBeAg negative with PEG‐interferon

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 3, 2015-03 ,pp. : 318-327

John Wiley & Sons Inc

Access to resources Recommend Favorite

Exacerbation of Darier disease by peg‐interferon beta‐1a in a patient suffering from multiple sclerosis

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 57, Iss. 1, 2018-01 ,pp. : 116-117

John Wiley & Sons Inc

Access to resources Recommend Favorite